Larenas-Linnemann D, Mayorga-Butrón JL, Sánchez-González A, Ramírez-García A, Medina-Ávalos M, Figueroa-Morales MA, Montaño-Velázquez BB, Montes-Narváez G, Romero-Tapia S, Stone-Aguilar H, Xochihua-Díaz L, Salas-Hernández J, Hernán-Ruiz H, Betancourt-Suárez MA, Cano-Salas MC, Curiel-Aceves L, Dibildox-Martínez J, Fernández-Vega M, García-Bolaños C, Iduñate-Palacios F, Jiménez-Chobillon MA, López-Lizárraga DN, Matta-Campos JJ, Olvera-Salinas J, Rivera-Gómez MA, Virgen-Ortega C, Sienra-Monge JJ, Del Río-Navarro B, Arias-Cruz A, Sacre-Hazouri A, Aguilar-Aranda A, Vásquez Del Mercado-Cordero R, Barnica RH, Velasco-Hidalgo L, Solís-Galicia C. [ARIA Mexico 2014. Adaptation of the Clinical Practice Guide ARIA 2010 for Mexico. Methodology ADAPTE].
Rev Alerg Mex 2014;
61 Suppl 1:S3-S116. [PMID:
24941973]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023] Open
Abstract
BACKGROUND
The global prevalence of allergic rhinitis is high. International Study of Asthma and Allergies in Childhood (ISAAC) Phase III reports a total estimated prevalence of 4.6% in Mexico. There is evidence based on allergic rhinitis Clinical Practice Guidelines (CPG), but its promotion, acceptance and application is not optimal or adequate in Mexico.
OBJECTIVE
To generate a guideline for the treatment of allergic rhinitis and its impact on asthma by adaptating the 2010 ARIA Guideline to Mexican reality, through a transculturation process applying the ADAPTE methodology.
PATIENTS AND METHOD
Using the ADAPTE Methodology, the original 2010 ARIA CPG recommendations were evaluated by the guideline development group (GDG) into which multiple medical specialities managing patients with allergic rhinitis were incoorporated. The GDG valorated the quality of 2010 ARIA, checked and translated key clinical questions. Moreover, the GDG adjusted recommendations, patient preferences and included comments in the context of the Mexican reality (safety, costs and cultural issues). To accomplish this, we ran Delphi panels with as many rounds as necessary to reach agreement. One extra question, not included in the original 2010 ARIA, on the use of Nasal Lavages for AR was created sustained by a systematic literature review.
RESULTS
A total of 45 questions from the original 2010 ARIA were included and divided into six groups covering prevention, medical treatment, immunotherapy and alternative medicine to treat patients with allergic rhinitis with or without asthma. Most of the questions reached agreement in one or two rounds; one question required three rounds.
CONCLUSIONS
An easy-to-use, adaptated, up-to-date and applicable allergic rhinitis guideline for Mexico is now available.
Collapse